These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 10845690

  • 1. The influence of carrier morphology on drug delivery by dry powder inhalers.
    Zeng XM, Martin GP, Marriott C, Pritchard J.
    Int J Pharm; 2000 Apr 25; 200(1):93-106. PubMed ID: 10845690
    [Abstract] [Full Text] [Related]

  • 2. Effects of particle size and adding sequence of fine lactose on the deposition of salbutamol sulphate from a dry powder formulation.
    Zeng XM, Martin GP, Tee SK, Ghoush AA, Marriott C.
    Int J Pharm; 1999 May 25; 182(2):133-44. PubMed ID: 10341303
    [Abstract] [Full Text] [Related]

  • 3. Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers.
    Zeng XM, MacRitchie HB, Marriott C, Martin GP.
    Int J Pharm; 2007 Mar 21; 333(1-2):45-55. PubMed ID: 17064863
    [Abstract] [Full Text] [Related]

  • 4. The use of different sugars as fine and coarse carriers for aerosolised salbutamol sulphate.
    Tee SK, Marriott C, Zeng XM, Martin GP.
    Int J Pharm; 2000 Nov 04; 208(1-2):111-23. PubMed ID: 11064216
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Characterisation and deposition studies of engineered lactose crystals with potential for use as a carrier for aerosolised salbutamol sulfate from dry powder inhalers.
    Larhrib H, Martin GP, Prime D, Marriott C.
    Eur J Pharm Sci; 2003 Jul 04; 19(4):211-21. PubMed ID: 12885385
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The contribution of different formulation components on the aerosol charge in carrier-based dry powder inhaler systems.
    Hoe S, Traini D, Chan HK, Young PM.
    Pharm Res; 2010 Jul 04; 27(7):1325-36. PubMed ID: 20354768
    [Abstract] [Full Text] [Related]

  • 12. Interaction of Formulation and Device Factors Determine the In Vitro Performance of Salbutamol Sulphate Dry Powders for Inhalation.
    Muddle J, Murnane D, Parisini I, Brown M, Page C, Forbes B.
    J Pharm Sci; 2015 Nov 04; 104(11):3861-3869. PubMed ID: 26220184
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of Granulated Lactose as a Carrier for Dry Powder Inhaler Formulations 2: Effect of Drugs and Drug Loading.
    Du P, Du J, Smyth HDC.
    J Pharm Sci; 2017 Jan 04; 106(1):366-376. PubMed ID: 27939234
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The influence of physical properties and morphology of crystallised lactose on delivery of salbutamol sulphate from dry powder inhalers.
    Kaialy W, Martin GP, Larhrib H, Ticehurst MD, Kolosionek E, Nokhodchi A.
    Colloids Surf B Biointerfaces; 2012 Jan 01; 89():29-39. PubMed ID: 21962946
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The influence of lactose carrier on the content homogeneity and dispersibility of beclomethasone dipropionate from dry powder aerosols.
    Zeng XM, Pandhal KH, Martin GP.
    Int J Pharm; 2000 Mar 20; 197(1-2):41-52. PubMed ID: 10704792
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.